Literature DB >> 16162004

Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex.

Maria A Miteva1, Wen H Lee, Matthieu O Montes, Bruno O Villoutreix.   

Abstract

A protocol was devised in which FRED, DOCK, and Surflex were combined in a multistep virtual ligand screening (VLS) procedure to screen the pocket of four different proteins. One goal was to evaluate the impact of chaining "freely available packages to academic users" on docking/scoring accuracy and CPU time consumption. A bank of 65 660 compounds including 49 known actives was generated. Our procedure is successful because docking/scoring parameters are tuned according to the nature of the binding pocket and because a shape-based filtering tool is applied prior to flexible docking. The obtained enrichment factors are in line with those reported in recent studies. We suggest that consensus docking/scoring could be valuable to some drug discovery projects. The present protocol could process the entire bank for one receptor in less than a week on one processor, suggesting that VLS experiments could be performed even without large computer resources.

Mesh:

Substances:

Year:  2005        PMID: 16162004     DOI: 10.1021/jm050262h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

1.  Are predefined decoy sets of ligand poses able to quantify scoring function accuracy?

Authors:  Oliver Korb; Tim Ten Brink; Fredrick Robin Devadoss Victor Paul Raj; Matthias Keil; Thomas E Exner
Journal:  J Comput Aided Mol Des       Date:  2012-01-10       Impact factor: 3.686

Review 2.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V.

Authors:  Kenneth Segers; Olivier Sperandio; Markus Sack; Rainer Fischer; Maria A Miteva; Jan Rosing; Gerry A F Nicolaes; Bruno O Villoutreix
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

4.  Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment.

Authors:  Alexandre Beautrait; Vincent Leroux; Matthieu Chavent; Léo Ghemtio; Marie-Dominique Devignes; Malika Smaïl-Tabbone; Wensheng Cai; Xuegang Shao; Gilles Moreau; Peter Bladon; Jianhua Yao; Bernard Maigret
Journal:  J Mol Model       Date:  2008-01-03       Impact factor: 1.810

5.  Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

Authors:  Andrew C Good; Tudor I Oprea
Journal:  J Comput Aided Mol Des       Date:  2008-01-09       Impact factor: 3.686

6.  Bias, reporting, and sharing: computational evaluations of docking methods.

Authors:  Ajay N Jain
Journal:  J Comput Aided Mol Des       Date:  2007-12-13       Impact factor: 3.686

7.  VSDMIP: virtual screening data management on an integrated platform.

Authors:  Rubén Gil-Redondo; Jorge Estrada; Antonio Morreale; Fernando Herranz; Javier Sancho; Angel R Ortiz
Journal:  J Comput Aided Mol Des       Date:  2008-10-22       Impact factor: 3.686

8.  In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.

Authors:  Amal Al-Aboudi; Raed A Al-Qawasmeh; Alaa Shahwan; Uzma Mahmood; Asaad Khalid; Zaheer Ul-Haq
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

9.  A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of (V600E)B-RAF inhibitors.

Authors:  Zaheer Ul-Haq; Uzma Mahmood; Sauleha Reza
Journal:  Mol Divers       Date:  2012-10-04       Impact factor: 2.943

10.  Gerontome: a web-based database server for aging-related genes and analysis pipelines.

Authors:  Jekeun Kwon; Byungwook Lee; Haeyoung Chung
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.